Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 20, 2004
"This quarter saw the achievement of a major milestone for Boston Scientific with the successful launch of TAXUS in the U.S.," said Jim Tobin, President and CEO.
-
Apr 19, 2004
Combines features from two of Boston Scientific's breakthrough technologies.
-
Apr 14, 2004
Boston Scientific will webcast its conference call with Q1 2004 financial results on Tuesday, April 20. A replay will also be available.
-
Apr 8, 2004
FDA clearance expands Company's family of high-performance self-expanding biliary stents
-
Apr 7, 2004
Acquisition brings high performance medical devices for use in accessing the brain, the heart and other areas of the anatomy. Learn more.
-
Apr 5, 2004
"All aspects of our U.S. TAXUS launch continue to go very well, and we are pleased that we are exceeding expectations," said Jim Tobin, President and Chief Executive Officer.
-
Apr 1, 2004
(April 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that the European Patent Office has declared invalid a patent held by Medinol Ltd. This is the patent that Boston...
-
Mar 31, 2004
(March 31, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has concluded enrollment in its TAXUS V de novo lesion clinical trial. The Company has enrolled 1,172...
-
Mar 29, 2004
(March 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Contour SE™...
-
Mar 25, 2004
(March 25, 2004) -- Boston Scientific Corporation (NYSE: BSX) and EndoTex Interventional Systems, Inc. announced today the completion of enrollment in a carotid artery stenting clinical trial to...